Benchmarking the In Vitro Activities of Moxifloxacin and Comparator Agents against Recent Respiratory Isolates from 377 Medical Centers throughout the United States

Samankaltaisia teoksia

• Activities of Faropenem, an Oral β-Lactam, against Recent U.S. Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
  Tekijä: Critchley, Ian A., et al.
  Julkaistu: (2002)
• Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States
  Tekijä: Sahm, Daniel F., et al.
  Julkaistu: (2000)
• Determining Linezolid’s Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Release
  Tekijä: Karlowsky, James A., et al.
  Julkaistu: (2002)
• Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001
  Tekijä: Critchley, Ian A., et al.
  Julkaistu: (2003)
• Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States
  Tekijä: Draghi, Deborah C., et al.
  Julkaistu: (2008)